HDEF - ETF AI Analysis
Top Page
Xtrackers MSCI EAFE High Dividend Yield Equity ETF (HDEF)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and over the past month, showing positive momentum for investors.
High-Quality Top Holdings
Several of the largest positions, including major consumer, healthcare, and energy companies, have shown strong or steady performance, supporting the fund’s returns.
Low Expense Ratio
The fund’s relatively low annual fee means more of the income and gains from its high-dividend strategy can stay in investors’ pockets.
Negative Factors
Concentration in a Few Countries
A large share of the portfolio is tied to the UK, Switzerland, and France, which increases the impact of economic or political issues in those markets.
Sector Skew Toward Defensive and Financial Names
Heavy exposure to general, consumer defensive, and financial sectors may limit upside if more growth-oriented areas of the market lead.
Not All Top Holdings Are Performing Strongly
At least one major holding has shown weaker recent performance, which can drag on overall returns if the trend continues.
HDEF vs. SPDR S&P 500 ETF (SPY)
AUM2.37B
RegionDeveloped Markets
Expense Ratio0.09%
Beta0.37
IssuerXtrackers
Inception DateAug 12, 2015
Dividend Yield3.65%
Asset ClassEquity
Index TrackedMSCI EAFE High Dividend Yield
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume97,779
30 Day Avg. Volume144,549
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
36.87Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering110
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HDEF Summary
HDEF is an ETF that follows the MSCI EAFE High Dividend Yield Index, focusing on companies in developed markets outside the U.S. and Canada, such as Europe and Japan. It mainly holds large, established businesses that pay relatively high dividends. Well-known names in the fund include Nestlé and Novartis. Someone might invest in HDEF to get regular income from dividends while also spreading their money across many international companies for diversification. A key risk is that international stock prices and currencies can move up and down, so the value of the ETF can rise or fall over time.
How much will it cost me?The expense ratio for HDEF is 0.09%, which means you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because HDEF is passively managed, tracking an index rather than relying on active stock selection.
What would affect this ETF?HDEF could benefit from stable dividend payouts and growth in developed markets outside North America, especially if sectors like financials and healthcare, which have significant weight in the ETF, perform well. However, challenges such as rising interest rates, economic slowdowns in Europe or Asia, or regulatory changes affecting top holdings like Novartis or Shell could negatively impact returns. Diversification across sectors and regions provides some resilience, but global economic conditions remain a key factor to watch.
HDEF Top 10 Holdings
HDEF leans heavily on a handful of global blue chips, with European health care and consumer staples setting the tone. Roche and Novartis have been steady climbers, quietly helping to prop up returns, while insurers like Allianz and Singapore’s DBS Group are giving the fund an extra lift with rising momentum. Energy names Shell and TotalEnergies are also pulling their weight, benefiting from a firmer commodity backdrop. On the flip side, consumer giants Nestlé and Unilever have been losing steam, acting as mild brakes on performance. Overall, it’s a diversified, income-focused basket across developed markets outside North America, but with a clear tilt toward Europe’s defensive stalwarts.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Shell (UK) | 5.17% | $121.44M | £197.02B | 30.81% | 73 Outperform | |
| Novartis AG | 5.06% | $118.71M | CHF237.20B | 24.62% | 80 Outperform | |
| Roche Holding AG | 5.03% | $118.15M | $353.49B | 28.54% | 73 Outperform | |
| Allianz | 4.66% | $109.36M | €170.64B | 28.18% | 67 Neutral | |
| Nestlé SA | 4.55% | $106.87M | CHF201.43B | 1.06% | 71 Outperform | |
| TotalEnergies SE | 4.01% | $94.16M | €169.87B | 42.48% | 78 Outperform | |
| ― | 3.50% | $82.13M | ― | ― | ― | |
| Iberdrola | 3.35% | $78.70M | €131.17B | 26.02% | 67 Neutral | |
| Unilever | 3.24% | $76.09M | £102.61B | -11.22% | 72 Outperform | |
| DBS Group Holdings | 2.99% | $70.28M | S$223.51B | 60.04% | 78 Outperform |
HDEF Technical Analysis
Positive
―
Price Trends
33.50
Positive
32.77
Positive
31.87
Positive
Market Momentum
0.19
Positive
60.52
Neutral
56.34
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HDEF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 34.06, equal to the 50-day MA of 33.50, and equal to the 200-day MA of 31.87, indicating a bullish trend. The MACD of 0.19 indicates Positive momentum. The RSI at 60.52 is Neutral, neither overbought nor oversold. The STOCH value of 56.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HDEF.
HDEF Peer Comparison
Comparison Results
Performance Comparison
HDEF
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
34.32
5.54
19.25%
IDV
iShares International Select Dividend ETF
―
―
―
DIVI
Franklin LibertyQ International Equity Hedged ETF
―
―
―
FGD
First Trust Dow Jones Global Select Dividend Index Fund
―
―
―
DTH
WisdomTree International High Dividend Fund
―
―
―
EFAS
Global X MSCI SuperDividend EAFE ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents